首页> 外文期刊>Biotechnology Letters >Recent advances in glycotechnology for glycoconjugate synthesis using microbial endoglycosidases
【24h】

Recent advances in glycotechnology for glycoconjugate synthesis using microbial endoglycosidases

机译:利用微生物糖苷内切酶合成糖缀合物的糖技术的最新进展

获取原文
获取原文并翻译 | 示例
       

摘要

Biotechnology associated with synthesis of glycopeptides and glycoproteins has recently advanced as glycotechnology. Studies toward glycotechonology include the artificial modification of sugar chains in glycoconjugates to improve their function because the physiological importance of sugar chains in living organisms is well recognized. Methods involving addition of oligosaccharides to peptides and proteins have attracted attention as efficient techniques in glycotechnology, especially those involving the transglycosylation activities of microbial endoglycosidases. The exploration of oligosaccharide oxazolines as donor substrates for the transglycosylation of endoglycosidases has significantly enhanced the efficiency of these processes. Moreover, discovery of novel endoglycosidase mutants with glycosynthase-like activity has made it possible to effectively synthesize large quantities of glycopeptides, as well as homogeneous glycoprotein. The use of mutant enzymes and oligosaccharide oxazolines has led to development of practical applications for the synthesis of bioactive glycopeptides and therapeutic glycoproteins as bio-medicines.
机译:与糖肽和糖蛋白合成相关的生物技术最近作为糖技术而发展。糖技术研究包括对糖缀合物中的糖链进行人工修饰以改善其功能,因为众所周知糖链在活生物体中的生理重要性。作为糖技术中的有效技术,涉及将寡糖添加到肽和蛋白质上的方法引起了人们的关注,特别是那些涉及微生物糖苷内切酶的转糖基化活性的方法。寡糖恶唑啉作为内切糖苷酶转糖基化的供体底物的探索已大大提高了这些过程的效率。此外,发现具有糖合酶样活性的新型糖苷内切酶突变体使得有效合成大量糖肽以及均质糖蛋白成为可能。突变酶和寡糖恶唑啉的使用已经导致了用于合成生物活性糖肽和治疗性糖蛋白作为生物医学的实际应用的开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号